| Literature DB >> 32683656 |
Vincenzo L'Imperio1, Virginia Brambilla2, Giorgio Cazzaniga2, Franco Ferrario2, Manuela Nebuloni3, Fabio Pagni2.
Abstract
Whole-slide imaging and virtual microscopy are useful tools implemented in the routine pathology workflow in the last 10 years, allowing primary diagnosis or second-opinions (telepathology) and demonstrating a substantial role in multidisciplinary meetings and education. The regulatory approval of this technology led to the progressive digitalization of routine pathological practice. Previous experiences on renal biopsies stressed the need to create integrate networks to share cases for diagnostic and research purposes. In the current paper, we described a virtual lab studying the routine renal biopsies that have been collected from 14 different Italian Nephrology centers between January 2014 and December 2019. For each case, light microscopy (LM) and immunofluorescence (IF) have been processed, analysed and scanned. Additional pictures (eg. electron micrographs) along with the final encrypted report were uploaded on the web-based platform. The number and type of specimens processed for every technique, the provisional and final diagnosis, and the turnaround-time (TAT) have been recorded. Among 826 cases, 4.5% were second opinion biopsies and only 4% were suboptimal/inadequate for the diagnosis. Transmission electron microscopy (TEM) has been performed on 41% of cases, in 22% changing the final diagnosis, in the remaining 78% contributed to the better definition of the disease. For light microscopy and IF the median TAT was of 2 working days, with only 8.6% with a TAT longer than 5 days. For TEM, the average TAT was 26 days (IQR 6-64). In summary, we systematically reviewed the 6-years long nephropathological experience of an Italian renal pathology service, where digital pathology is a definitive standard of care for the routine diagnosis of glomerulonephritides.Entities:
Keywords: Digital pathology; Renal biopsy; Renal pathology; Telepathology
Year: 2020 PMID: 32683656 PMCID: PMC8192318 DOI: 10.1007/s40620-020-00805-1
Source DB: PubMed Journal: J Nephrol ISSN: 1121-8428 Impact factor: 3.902
Fig. 1a The instrumentation employed in the facility of ASST Monza. On the left Aperio CS2 device for light microscopy and Aperio ScanScope FL for immunofluorescence on the right. b The single case as it is displayed in the platform Spectrum for every afferent center. On the upper left black box is the section with the details of the case (histological progressive number, name of the patient, final diagnosis, eventual notes and the data group, corresponding to each afferent center). On the upper right black box is the section dedicated to the additional attachments, such as the final report, electron micrographs and pictures captured from ancillary techniques (immunohistochemistry or Congo Red stain). On the bottom of the picture the rows with virtual slides of the case, with both light microscopy and immunofluorescence, associated with the appropriate barcode to ensure the correct identification of the patient
Fig. 2a Distribution and frequency of the final diagnosis per year. MN membranous nephropathy, MCD minimal change disease, FSGS focal segmental glomerulosclerosis, IgA IgA nephropathy, LN lupus nephritis, DN diabetic nephropathy, ANS arterionephrosclerosis, ANCA pauci immune crescentic glomerulonephritis, ANTI GBM Anti-GBM glomerulonephritis, LCCN light chain cast nephropathy, IRGN infection related glomerulonephritis, MIDD monoclonal immunoglobulin deposition disease, TMA thrombotic microangiopathy, AIN acute interstitial nephritis; OTHERS: some of the other rare diagnosis were represented by acute pyelonephritis, Alport syndrome and thin basement membrane lesion, cryoglobulinemic glomerulonephritis, fibrillary glomerulonephritis, immunotactoid glomerulonephritis, renal lymphoma, atheroembolic disease, IgA vasculitis and much rarer diseases. b The distribution of cases on the base of the TAT. The majority of them were managed within 2–3 working days (median 2, IQR 1–3) and only 8.6% (71) cases had a TAT > 5 days (half of them, 37, coming from the South of Italy)
Fig. 3A case of mesangioproliferative glomerulonephritis in a patient with mixed connective tissue disease (MCTD). Original immunofluorescence (first column), captured with a static camera associated with the microscope, showed the presence of IgM dominant immune complexes, consistent with a MCTD-associated immune complex glomerulonephritis. The automated scan using the focus and exposition time preset by Aperio device (middle column) failed to demonstrate the prevalence of IgM antisera, showing even higher intensity for C3. Adjusting the focus and exposition time manually adopting the settings of the static camera (last column) the results were more comparable with the original
Fig. 4The creation of a network with spokes (nephrology centers that perform the biopsy) and hubs (big pathology centers with electron microscopy and digital pathology facilities) allows the referral clinician to rely on the expertise of specialist with a consolidated experience in the field of renal pathology. On the other hand, the hubs can communicate for second opinion and research purposes